SCHEMBL6062233

SCHEMBL6062233

C=CCc1ccc(CC=C)c(Oc2ccc(OC)cc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
CYP3A4 P08684 3/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
TP53 P04637 1/20 0.62
ALOX15 P16050 1/20 0.62
TSHR P16473 1/20 0.62
ALOX12 P18054 1/20 0.62
PPARA Q07869 2/20 0.57
PPARG P37231 1/20 0.57
PPARD Q03181 1/20 0.57
ALOX5 P09917 3/20 0.53
PTGS1 P23219 2/20 0.53
AR P10275 1/20 0.53
TRPM8 Q7Z2W7 1/20 0.53
GABRA1 P14867 4/20 0.49
GABRB2 P47870 4/20 0.49
CNR2 P34972 2/20 0.49
MAPT P10636 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
FFAR4 Q5NUL3 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6062868 0.85 ALDH1A1 (0.49) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL17537909 0.84 ALDH1A1 (0.73) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
Estragole SCHEMBL28095175 0.78 ALDH1A1 (1.00) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
Estragole SCHEMBL900647 0.78 ALDH1A1 (1.00) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
Estragole SCHEMBL57204 0.78 ALDH1A1 (1.00) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL2845262 0.77 APLNR (0.58) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL11769802 0.77 XDH (0.53) ALDH1A1CYP3A4SMN1; SMN2PPARAPPARG
SCHEMBL30105464 0.77 APLNR (0.58) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
Estragole SCHEMBL29106756 0.77 ALDH1A1 (0.69) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL2096402 0.77 ALDH1A1 (0.57) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105577-B2 for finishing of undyed and dyed or printed fibre materials; treatment of skin, mucous membrane or hair, hard surfaces, oral care; detergent CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-09-12 US disclosed
US-20040186174-A1 Hydroxydiphenyl ether compounds HOLZL WERNER (FR) 2004-09-23 US disclosed
US-20030162836-A1 Hydroxydiphenyl ether compounds HOLZL WERNER (FR) 2003-08-28 US disclosed
EP-1053989-A2 Hydroxydiphenyl ether compounds Ciba SC Holding AG (CH) 2000-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186174-A1 Hydroxydiphenyl ether compounds HPD, DDT, HAAO ALDH1A1 1109/4885CYP3A4 5/4885SMN1; SMN2 4792/4885
US-20030162836-A1 Hydroxydiphenyl ether compounds HPD, DDT, HAAO ALDH1A1 1109/4885CYP3A4 5/4885SMN1; SMN2 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.